A to Z Drug Facts
[book on CD-ROM]. 2nd ed. St. Louis, Mo: Facts and Comparisons; 2000.
Takanaga H, Ohnishi A, Murakami H, et al. Relationship between time after intake of grapefruit juice and the effect on pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects.
Clin Pharmacol Ther.
2000;67:201 - 214.
Ernst E. Second thoughts about safety of St. John's wort.
Lancet.
1999;354:2014 - 2016.
Guengerich FP. Cytochrome P-450 3A4: regulation and role in drug metabolism.
Annu Rev Pharmacol Toxicol.
1999;39:1 - 17.
Ruschitzka F, Meier PJ, Turina M, et al. Acute heart transplant rejection due to Saint John's wort [letter].
Lancet.
2000;355:548 - 549.
Breidenbach T, Hoffmann MW, Becker T, et al. Drug interaction of St John's wort with cyclosporin.
Lancet.
2000;355:1912.
Barone GW, Gurley BJ, Ketel BL, et al. Drug interaction between St. John's wort and cyclosporine.
Ann Pharmacother.
2000;34:1013 - 1016.
Agnusdei D, Bufalino L. Efficacy of ipriflavone in established osteoporosis and long-term safety.
Calcif Tissue Int.
1997;61(suppl 1):S23 - S27.
Alexandersen P, Toussaint A, Christiansen C, et al. Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial.
JAMA.
2001;285:1482 - 1488.
Wacher VJ, Wong S, Wong HT. Peppermint oil enhances cyclosporine oral bioavailability in rats: comparison with D-alpha-tocopheryl poly(ethylene glycol 1000) succinate (TPGS) and ketoconazole.
J Pharm Sci. 2002;91:77-90.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.